CPC
ABBV icon

Cookson Peirce & Co’s AbbVie ABBV Stock Holding History

Cookson Peirce & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,704
Closed -$590K – 214
2023
Q1 		$590K Sell
3,704
-3,212
-46% -$491K 0.04% 132
2022
Q4 		$1.12M Sell
6,916
-1,370
-17% -$210K 0.07% 99
2022
Q3 		$1.11M Buy
8,286
+346
+4% +$49.7K 0.08% 97
2022
Q2 		$1.22M Buy
7,940
+882
+12% +$135K 0.08% 94
2022
Q1 		$1.14M Buy
7,058
+1,766
+33% +$257K 0.07% 107
2021
Q4 		$717K Buy
5,292
+183
+4% +$21.6K 0.04% 131
2021
Q3 		$551K Sell
5,109
-337,982
-99% -$38.6M 0.03% 146
2021
Q2 		$38.6M Buy
343,091
+11,531
+3% +$1.3M 2.4% 7
2021
Q1 		$35.9M Buy
331,560
+183,677
+124% +$19.6M 2.35% 10
2020
Q4 		$15.8M Buy
+147,883
New +$14.2M 1.08% 38
2015
Q1 		– Sell
-9,719
Closed -$636K – 124
2014
Q4 		$636K Buy
+9,719
New +$613K 0.13% 88

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cookson Peirce & Co's ABBV Position: Q2 2023 in Review

Cookson Peirce & Co sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 3,704 shares — an estimated $590K sold.

Cookson Peirce & Co first reported a position in ABBV in Q4 2014 and held it in 11 quarters. The position peaked at $38.6M in Q2 2021. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Cookson Peirce & Co reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Cookson Peirce & Co sold 3,704 AbbVie shares in Q2 2023, an estimated $590K.
  • Cookson Peirce & Co first reported a position in AbbVie in Q4 2014 and held it in 11 quarters.
  • Cookson Peirce & Co's AbbVie position peaked at $38.6M in Q2 2021.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Cookson Peirce & Co's 13F filing for Q2 2023, filed 1 Aug 2023.